Advice
Following a full submission
Bemiparin (Zibor) is not recommended for use within NHS Scotland for the treatment of established deep vein thrombosis, with or without pulmonary embolism, during the acute phase.
Greater numbers of patients had a reduction in thrombus size with bemiparin than unfractionated heparin, but bemiparin has not been compared with other low molecular heparins.
Cost effectiveness has not been demonstrated.
Download detailed advice43KB (PDF)
Medicine details
- Medicine name:
- Bemiparin, 25,000 IU/ml injection for sub-cutaneous administration
- SMC ID:
- 206/05
- Indication:
- Treatment of established deep vein thrombosis, with or without pulmonary embolism, during acute phase
- Pharmaceutical company
- Amdipharm PLC
- BNF chapter
- Cardiovascular system
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 10 October 2005